|
estrogen |
9 |
|
mendelian randomization |
9 |
|
mendelian randomization analysis |
9 |
|
uk biobank |
8 |
|
bronchopulmonary dysplasia |
7 |
|
infant |
7 |
|
menarche |
7 |
|
premature |
7 |
|
supplemental oxygen |
7 |
|
cardiovascular disease |
6 |
|
china |
6 |
|
coronary heart disease |
6 |
|
genetic risk |
6 |
|
breast feeding |
5 |
|
cardiovascular risk factors |
5 |
|
chinese |
5 |
|
cholesterol |
5 |
|
cognition |
5 |
|
cognition - physiology |
5 |
|
cohort studies |
5 |
|
estrogens - physiology |
5 |
|
menarcheal age |
5 |
|
menopause |
5 |
|
postmenopause - blood - psychology |
5 |
|
puberty |
5 |
|
reproductive history |
5 |
|
risk factors |
5 |
|
testosterone |
5 |
|
women |
5 |
|
adiposity |
4 |
|
children |
4 |
|
cognitive function |
4 |
|
depressive symptoms |
4 |
|
epidemiology |
4 |
|
hematocrit |
4 |
|
hemoglobin |
4 |
|
sleep duration |
4 |
|
sugar-sweetened beverages |
4 |
|
hba1c |
3 |
|
healthy lifestyle |
3 |
|
hypertension |
3 |
|
linearity |
3 |
|
mendelian randomisation |
3 |
|
physical activity |
3 |
|
sedentary behavior |
3 |
|
stroke |
3 |
|
cancer |
2 |
|
cardiometabolic diseases |
2 |
|
general population |
2 |
|
genetics |
2 |
|
glucose |
2 |
|
hba1c hemoglobin |
2 |
|
ischemic heart disease |
2 |
|
metformin targets |
2 |
|
non-diabetic individuals |
2 |
|
vascular endothelial growth factor |
2 |
|
all-cause mortality |
1 |
|
cause-specific mortality |
1 |
|
cohort |
1 |
|
eczema |
1 |
|
menopausal hormone therapy |
1 |
|
prenatal depressive symptoms |
1 |
|
time-varying mortality estimates |
1 |
